XBiotech (XBIT)

XBiotech (XBIT) Financial Statements


XBiotech Financial Overview

XBiotech's market cap is currently ―. The company's EPS TTM is $-1.083; its P/E ratio is -3.16; XBiotech is scheduled to report earnings on May 9, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 300.00K$ 1.68M$ 1.53M$ 500.00K$ 4.50M
Gross Profit$ 284.00K$ 1.47M$ 1.32M$ 287.00K$ 3.45M
EBIT$ -8.16M$ -6.39M$ -12.09M$ -7.84M$ -7.19M
EBITDA$ -7.72M$ -5.66M$ -11.37M$ -7.13M$ -6.49M
Net Income Common Stockholders$ -3.20M$ -12.66M$ -11.64M$ -5.39M$ -6.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 217.48M$ 220.10M$ 225.79M$ 231.82M$ 236.98M
Total Assets$ 246.10M$ 250.83M$ 266.46M$ 270.80M$ 275.18M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -217.48M$ -220.10M$ -225.79M$ -231.82M$ -236.98M
Total Liabilities$ 5.70M$ 6.03M$ 10.67M$ 5.24M$ 5.79M
Stockholders Equity$ 240.40M$ 244.81M$ 255.79M$ 265.56M$ 269.38M
Cash Flow-
Free Cash Flow$ 2.57M$ -6.24M$ -6.46M$ -5.28M$ -2.23M
Operating Cash Flow$ 2.70M$ -6.03M$ -6.38M$ -5.12M$ -1.76M
Investing Cash Flow$ -3.91M$ -59.74M$ -82.00K$ -161.00K$ -476.00K
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 33.00K
Currency in USD

XBiotech Earnings and Revenue History

XBiotech Debt to Assets

XBiotech Cash Flow

XBiotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis